Glaxo threatens Govts with 'unintended consequences'

Drugs giant GlaxoSmithKline today called on European governments to halt aggressive price cuts on medicines or suffer “unintended consequences”.

The group warned that austerity drives across Europe, which have seen medicine prices slashed by more than 7%, will impact the development of new drugs across the continent.